JNc-440
JNc-440 is a potent antihypertensive agent. JNc-440 can enhance the interaction of TRPV4 and Ca2+-activated potassium channel 3 (KCa2.3) in endothelial cells. JNc-440 can also enhance vasodilation, and exerted antihypertensive effects in mice[1].
Product Specifications
CAS Number
1119503-63-7
UNSPSC
12352005
Target
Potassium Channel; TRP Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/jnc-440.html
Purity
98.04
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(C(N1)=NC2=C(C=CC=C2)C1=O)NCCCNC(C(C3=CC=CC=C3)C4=CC=CC=C4)=O
Molecular Formula
C26H24N4O3
Molecular Weight
440.50
References & Citations
[1]He D, et al. Treatment of hypertension by increasing impaired endothelial TRPV4-KCa2.3 interaction. EMBO Mol Med. 2017 Nov;9 (11) :1491-1503.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
TRPV4
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![Human Monoclonal IL-13 Antibody (dectrekumab) [mFluor Violet 610 SE]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
Human Monoclonal IL-13 Antibody (dectrekumab) [mFluor Violet 610 SE]